Yüklüyor......
Pyrotinib versus trastuzumab emtansine for HER2-positive metastatic breast cancer after previous trastuzumab and lapatinib treatment: a real-world study
BACKGROUND: To compare the efficacy and safety of pyrotinib and trastuzumab emtansine (T-DM1) in patients who experienced disease progression on trastuzumab and lapatinib treatment. METHODS: This was a real-world study that included cases of metastatic breast cancer (MBC) with trastuzumab and lapati...
Kaydedildi:
| Yayımlandı: | Ann Transl Med |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7867920/ https://ncbi.nlm.nih.gov/pubmed/33569405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-4054 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|